Comparing Sox2+ cells in vehicle-treated and vismodegib-treated tumors and stratifying using Yfp expression and the markers identified by Vanner et al.31, we identified subsets that were relatively depleted or enriched by vismodegib treatment, including Sox2+ cells of tumor lineage (Fig. 8f). Here, SOX2 is linked to neoplasm.